All IndicationsOncology
🎗️
first-line treatment for advanced triple-negative breast cancer (TNBC)
1
Companies
1
Drug Programs
0
Phase 3
0
Upcoming PDUFAs
Competitors
| Company | Drug | Phase | Designations | Timeline | Trial ID |
|---|---|---|---|---|---|
| SKBBY Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | sac-TMT | — | — | — | — |
Development Stage Distribution
Unknown
1
PDUFA Timeline
No upcoming PDUFA dates for this indication.
Not financial advice
Signals are probabilistic and based on historical data — past performance doesn't guarantee future results. Do your own research.
